Search for: "Bayer v. State"
Results 581 - 600
of 695
Sorted by Relevance
|
Sort by Date
3 Jul 2008, 7:26 pm
State-law injury issues not addressed.Wood v. [read post]
3 Jun 2022, 8:02 am
Roskomnadzor v. [read post]
17 Apr 2008, 10:39 am
Bayer AG, 735 N.W.2d 448, 467-68 (Wis. 2007) (drug approvals and possibly other FDA documents); Horne v. [read post]
6 Jan 2012, 4:13 pm
That would be consistent with the Supreme Court’s decision this year in Smith v. [read post]
29 Dec 2011, 6:53 am
Garza v. [read post]
1 May 2014, 4:59 am
At most, Teva could have sought assistance from the FDA in convincing Bayer to adopt a stronger label for Yaz so it could do the same with regard to Gianvi. [read post]
24 Feb 2017, 12:04 pm
The most striking example of apparently mistaken incontestability comes from B&B v. [read post]
10 Sep 2010, 1:05 am
Supreme Court's Lewis v. [read post]
14 Aug 2020, 9:02 am
Bayer Healthcare et al., Case No. 5:20-cv-00102 (N.D. [read post]
31 Aug 2011, 3:37 pm
John Fund v. [read post]
31 May 2012, 4:24 am
” Estate of Frankl v. [read post]
9 Dec 2023, 7:39 am
” Fosse v. [read post]
4 Nov 2009, 5:17 am
You can find the full opinion in Scott v. [read post]
25 Apr 2014, 7:38 pm
See DuoProSS Meditech Corp. v. [read post]
4 Nov 2009, 5:17 am
You can find the full opinion in Scott v. [read post]
8 May 2011, 8:13 am
., et al. v. [read post]
14 Mar 2024, 10:07 am
Last week, Bayer broke its Philadelphia losing streak, with a win in Kline v. [read post]
13 Apr 2018, 8:58 am
INS v. [read post]
6 Jul 2023, 2:55 am
Although the Court of Appeal was clear, in Neurim v Generics [2020] EWCA Civ 793, that deciding to uphold the lower court’s decision not to grant a pharmaceutical patent PI was based on the specific facts of that case, the Patents Court has subsequently refused two further pharmaceutical PIs (Neurim v Teva [2022] EWHC 954 (Pat) and [2022] EWHC 1641(Pat), and Novartis v Teva [2022] EWHC 959 (Ch)). [read post]
18 Jul 2019, 11:24 pm
But, at least for now, the related case law in the United States is fundamentally better than in Germany, though this may be attributable in no small part to the historic happenstance of what cases were put before the courts in what sequence--and what questions for review the parties raised.Just so there is no misunderstanding: Dr. [read post]
